Sector Snapshot: Will The Energy Surge Continue?
Mar 23, 2016
Jeremy Parkinson
Finance
The last month has seen a shift in the fortunes of energy stocks with the sector leading the pack with a return over 11%. Will it last? That probably depends more on the direction of the US dollar than it does any of the alleged production agreements that get so much press and rarely produce […]
EUR/USD And GBP/USD Forecast – March 23, 2016
Mar 23, 2016
Jeremy Parkinson
Finance
EUR/USD The EUR/USD pair fell during the course of the day on Tuesday, testing the 1.12 level. There is an area that is supportive near that handle, and as a result it looks like the buyers will get involved sooner or later. I also believe that the Federal Reserve stepping away from the extremely hawkish […]
New Home Sales Near Consensus On Muddle-Through Track
Mar 23, 2016
Jeremy Parkinson
Finance
Following last month’s dismal showing, new home sales rebounded pretty much in-line with estimates, with the Western region leading the way. Year-on-year sales are up in the West by 10.2% and the Midwest by 1.2%. Sales are down in 3.8% in the Northeast, and 14.3% in the South. There is not a lot of overall […]
Capitalist System & Share Buybacks With John Rubino
Mar 23, 2016
Jeremy Parkinson
Finance
At what point central planners will reveal themselves? Yellen, and the others are employees. Who is behind these policies? This system is totally ridiculous. Video Length: 00:34:13
Major Signals Suggest New Gold Bull Market Coming Soon?
Mar 23, 2016
Jeremy Parkinson
Finance
Written by Austrolib Assuming the fundamental argument of the gold bulls is correct and that: a rising dollar supply means rising price inflation, a rising price inflation means a rising gold price (and over the last century that is certainly the case) the question is did we just see a major trend change? What follows are […]
Staying Cautious On Corvus Pharma IPO
Mar 23, 2016
Jeremy Parkinson
Finance
Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) expects to raise $67.8 million in its upcoming IPO. Based in Burlingame, California, Corvus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development and marketing of immune-based cancer treatments. We previewed CRVS on our IPO Insights platform. CRVS will offer 4.7 million shares at an expected price range of $15 to $17. […]
The CAC 40 Fails To Find Direction
Mar 23, 2016
Jeremy Parkinson
Finance
The CAC 40 is trading up .23% this morning, as the Index looks poised to consolidate for the ninth consecutive day. For the session, LafarageHocim is leading the Index trading up 2.41%. Conversely, Unibal has the biggest decline for Wednesday trading down -1.82%. Technical traders should note that the CAC 40 is still trading inside […]
S&P 500 And Nasdaq 100 Forecast – March 23, 2016
Mar 23, 2016
Jeremy Parkinson
Finance
S&P 500 The S&P 500 fell initially during the course of the day on Tuesday, testing the 2040 level for support. We found it there though, and therefore ended up turning back around and formed a hammer. Obviously, I feel that this is a very bullish sign and as a result if we can break […]
E
Taking Profits On Our Short Russell 2000 Put Spread
Mar 23, 2016
Jeremy Parkinson
Finance
I am going to use the Brussels terrorist attack to take a quickie profit on our position in the Russell 2000 iShares ETF (IWM) April, 2016 $112-$117 in-the-money vertical bear put spread. Profits have been few and far between lately, and a 7.26% profit in 11 trading days is not bad. At $4.77 we are […]
Two Down – Two To Go
Mar 23, 2016
Jeremy Parkinson
Finance
The Federal Reserve’s years-long campaign to sheepishly back away from its own policy forecasts continued in earnest last week when it officially reduced the four expected 2016 quarter point hikes, suggested back in December, to just two. Given the deteriorating economic outlook, I believe there can be little doubt that the Fed will soon complete the capitulation […]